MCRB (STOCKS)
Seres Therapeutics, Inc.
$5.620000
-0.080000 (-1.40%)
Prev close: $5.700000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Richard N. Kender
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $53.50M
- Employees
- 103
- P/E (TTM)
- -1.14
- P/B (TTM)
- 2.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-2.08 | $-1.92 | -0.1624 | -8.47% |
|
Dec 2025 (Q4)
|
$-1.78 | $-2.15 | +0.3722 | +17.29% |
|
Sep 2025 (Q3)
|
$0.94 | $1.31 | -0.3656 | -28.00% |
|
Jun 2025 (Q2)
|
$-2.27 | $-2.54 | +0.2724 | +10.71% |
Financial Statements
| Revenues | $1.15M |
| Nonoperating Income/Loss | $40.74M |
| Operating Expenses | $88.79M |
| Research and Development | $50.43M |
| Other Operating Expenses | $38.36M |
| Operating Income/Loss | -$87.64M |
| Income/Loss From Continuing Operations After Tax | -$46.90M |
| Income/Loss From Continuing Operations Before Tax | -$26.63M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$46.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$46.90M |
| Net Income/Loss Available To Common Stockholders, Basic | -$46.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.18 |
| Diluted Earnings Per Share | -$5.17 |
| Basic Average Shares | 27,208,515 |
| Diluted Average Shares | 27,222,730 |
| Assets | $117.62M |
| Current Assets | $31.84M |
| Noncurrent Assets | $85.78M |
| Fixed Assets | $6.85M |
| Other Non-current Assets | $78.93M |
| Liabilities | $91.12M |
| Current Liabilities | $19.34M |
| Accounts Payable | $2.34M |
| Wages | $1.84M |
| Other Current Liabilities | $15.17M |
| Noncurrent Liabilities | $71.78M |
| Equity | $26.50M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $26.50M |
| Liabilities And Equity | $117.62M |
| Net Cash Flow From Operating Activities | -$42.15M |
| Net Cash Flow From Operating Activities, Continuing | -$42.15M |
| Net Cash Flow From Investing Activities | $15.92M |
| Net Cash Flow From Investing Activities, Continuing | $15.92M |
| Net Cash Flow From Financing Activities | $13.15M |
| Net Cash Flow From Financing Activities, Continuing | $13.15M |
| Net Cash Flow | -$13.08M |
| Net Cash Flow, Continuing | -$13.08M |
| Comprehensive Income/Loss | -$46.90M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$46.90M |
| Other Comprehensive Income/Loss | $5.70M |